Featured CME Programs

Upcoming CME Events

• 

  Atlantic Regional Hematopathology Meeting Future Directions of Hematopathology

  Advances in hematopathology, as well as in molecular and genetic information, are evolving at a rapid rate. However, it is difficult to remain current with the latest advances, let alone interpret their meaning and applicability to diagnosis and therapy. This meeting will focus on the “Future Directions of Hematopathology” with emphasis on the role of molecular pathology and new technologies in the diagnosis, prognostic stratification and treatment of challenging cases. Participants will be asked to incorporate advances in molecular and genetic information indicators/markers and test results in order to enhance interpretation of complex cases.

  Complimentary registration for all participants; includes breakfast, lunch, coffee breaks and program

  CME Registration Deadline: Wednesday, May 17, 2023

  Register

  Details

  Saturday, May 20, 2023
  8:30AM–3:00 pm EST Exhibit Hall Open

  Fox Chase Cancer Center Auditorium
  333 Cottman Avenue
  Philadelphia, PA 19111

  View Event Flyer

  View Agenda

  Submission of Abstracts

  We invite you to submit abstracts of clinical, scientific, and educational value with a focus on the role of molecular pathology and new technologies in the diagnosis, prognostic stratification and treatment of challenging cases.

  To submit an abstract for consideration, please send the following by Monday, April 3, 2023 to [email protected]:

  1. 1-page abstract, case description and diagnosis in a Word document (NO SLIDES)
  2. In the abstract, please specify the name, credential, affiliation and email of the person presenting the case if selected for oral presentation

  Notification of cases selected will be via email.

  ... Expand

  If you are selected for ORAL PRESENTATION, please follow these instructions:

  • Presentations consist of a 15-minute lecture
  • You will receive an email from "eeds" (the CME software) requesting you to upload the following by Monday, May 8, 2023:
    1. Set of PowerPoint slides with a brief patient history and a couple of pictures to post on the eeds site prior to the event for reference—please abstain from providing a diagnosis or any discussion. Please title your slides as follow: “Presenter’s last name, first initial-WITH DIAGNOSIS-Title”
    2. Electronic copy of your PowerPoint slides as you will present them. Please title your slides as follow: “Presenter’s last name, first initial-WITH DIAGNOSIS-Title”
    3. Speaker disclosure of the person presenting the case

  If you are selected for POSTER EXHIBIT, please follow these instructions:

  • Poster exhibits will be displayed all day and can be presented during breaks.
  • Please bring a hard copy of your poster on the day of the event
    • 4'x6' poster boards with stands will be available

  Intended Audience

  Hematopathologists, pathologists of other subspecialties, hematologists/oncologists, radiation oncologists, internists, primary care providers, fellows and residents of pathology, oncology and other specialties

  Inquiries

  Lucía Tono, PhD, MEd: 215-728-3797
  [email protected]

  Presenters

  Keynote Speakers

  Jeffrey Medeiros, MD
  Professor & Chairman, Department of Hematopathology, MD Anderson Cancer Center

  Mariusz Wasik, MD
  Professor & Chair of Pathology; Associate Director of Cancer Center; DE&S Morel, S&S Bayster Chair in Molecular Diagnosis, Fox Chase Cancer Center

  Program Director

  Reza Nejati, MD
  Associate Professor; Director, Flow Cytometry Lab; Medical Director of TUH-FCCC Clinical Laboratories; Department of Pathology, Fox Chase Cancer Center

  Planning Committee Members

  Mariusz Wasik, MD
  Professor & Chair of Pathology; Associate Director of Cancer Center; DE&S Morel, S&S Bayster Chair in Molecular Diagnosis, Fox Chase Cancer Centery

  Nicholas Mackrides, MD
  Assistant Professor, Department of Pathology, Fox Chase Cancer Center

  Tahseen I. Al-Saleem, MD
  Professor Emeritus, Department of Pathology, Fox Chase Cancer Center

  Henry C. Fung, MD, FACP, FRCPE
  Vice-Chair, Department of Hematology/Oncology; Chief, Section of Hematologic Malignancies; Director, Fox Chase – Temple University Hospital; BMT Program, Fox Chase Cancer Center

  Learning Objectives

  After attending this program, participants should be able to:

  At the end of this activity, participants should be able to:

  • Recognize the indicators/markers and test results to look for in complex cases to aid in diagnosis
  • When appropriate, incorporate recent molecular immunophenotypic and genetic information when interpreting results, determining diagnoses and selecting therapies
  • Discuss the latest advances related to the characteristics of progression in B-cell lymphomas

  Accreditation Statement

  The Temple Health Office for Continuing Medical Education is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians.

  Certification Statement

  The Temple Health Office for Continuing Medical Education designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the educational activity Collapse